Samuel Blackman

Samuel Blackman has an extensive background in the pharmaceutical industry, with experience in various companies such as Day One Biopharmaceuticals, Presage Biosciences, Inc., and Notable. With a strong education in Medicine, Pharmacology, and Philosophy from the University of Illinois College of Medicine and University of Chicago, Blackman has held roles such as Founder and Head of Research and Development at Day One Biopharmaceuticals and Senior Vice President, Head of Clinical Development at Silverback Therapeutics. Additionally, Blackman has experience in clinical leadership roles at companies like Juno Therapeutics and Seattle Genetics.